2-YEAR-OLD girl undergoing therapy for acute lymphoblastic leukemia was also receiving home treatment with intravenous (IV) antibiotics for a central line infection. A subcutaneous device (Port-A-Cath; Horizon Medical Products Inc, Manchester, Ga) was in place to facilitate chemotherapy. The acute lymphoblastic leukemia was in remission 6 months after the initial diagnosis. One week prior to this illness, the patient was hospitalized for Escherichia coli bacteremia and, once blood cultures were sterile, was discharged to complete a course of IV antibiotics at home. The patient's mother had received instructions on how to administer the medications through the central venous catheter (CVC) previously and again during the recent hospitalization. She had received IV treatment at home for 5 days,